Abstract
Acute respiratory distress syndrome (ARDS) is one of the most common respiratory acute and critical diseases in newborns...
Highlights
Acute respiratory distress syndrome (ARDS) is one of the most common respiratory acute and critical diseases in newborns
In view of the fact that the treatment of neonatal Acute Respiratory Distress Syndrome (ARDS) is only limited to the comprehensive treatment based on the corresponding respiratory support therapy, it is the focus of every neonatal pediatrician to understand the pathogenesis and diagnostic criteria of ARDS and actively take reasonable treatment measures
The results showed that the activity of type II secretory phospholipase A2 was increased in both adults and children with ARDS
Summary
Acute respiratory distress syndrome (ARDS) is one of the most common respiratory acute and critical diseases in newborns. There are no effective treatment measures for neonatal ARDS, the main treatment methods include respiratory support, PS replacement, extracorporeal membrane oxygenation therapy, nutritional support and liquid management. The consensus meeting on Acute Lung injury in Children recommended that children with ARDS should use NIPPV, and PEEP noninvasive ventilation at an early stage of the disease [8].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Biomedical Journal of Scientific & Technical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
